Diagnostic Imaging Collaboration and Licensing Deals 2016-2026

Diagnostic Imaging Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2016
•    Browse diagnostic imaging collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in diagnostic imaging dealmaking
2.1. Introduction
2.2. Diagnostic imaging deals over the years
2.3. Most active diagnostic imaging dealmakers
2.4. Diagnostic imaging deals by deal type
2.5. Diagnostic imaging deals by therapy area
2.6. Diagnostic imaging deals by industry sector
2.7. Deal terms for diagnostic imaging deals
2.7.1 Diagnostic imaging deals headline values
2.7.2 Diagnostic imaging deal upfront payments
2.7.3 Diagnostic imaging deal milestone payments
2.7.4 Diagnostic imaging royalty rates

Chapter 3 – Leading diagnostic imaging deals
3.1. Introduction
3.2. Top diagnostic imaging deals by value

Chapter 4 – Most active diagnostic imaging dealmakers
4.1. Introduction
4.2. Most active diagnostic imaging dealmakers
4.3. Most active diagnostic imaging deals company profiles

Chapter 5 – Diagnostic imaging contracts dealmaking directory
5.1. Introduction
5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 – Diagnostic imaging dealmaking by technology type

Deal directory

Deal directory – Diagnostic imaging deals by company A-Z
Deal directory – Diagnostic imaging deals by deal type
Deal directory – Diagnostic imaging deals by therapy area

Deal type definitions

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

 
Table of figures

Figure 1: Diagnostic imaging deals since 2016
Figure 2: Active diagnostic imaging dealmaking activity
Figure 3: Diagnostic imaging deals by deal type since 2016
Figure 4: Diagnostic imaging deals by therapy area since 2016
Figure 5: Diagnostic imaging deals by industry sector since 2016
Figure 6: Diagnostic imaging deals with a headline value
Figure 7: Diagnostic imaging deals with an upfront value
Figure 8: Diagnostic imaging deals with a milestone value
Figure 9: Diagnostic imaging deals with a royalty rate value
Figure 10: Top diagnostic imaging deals by value since 2016
Figure 11: Most active diagnostic imaging dealmakers
Figure 12: Diagnostic imaging deals by technology type since 2016

Pricing options

• $3,995: single-user (encrypted file - one user/device)
• $5,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

3B Pharmaceuticals, 3Derm Systems, 3M, 22nd Century, Abbott Laboratories, Abbvie, Abcam, Abramson Cancer Center, ABX, ABX-CRO Advanced Pharmaceutical Services, Accudata Systems, Accuray, Acibadem University, AC Immune, ACIST Medical Systems, Acoustic MedSystems, Actelion, Acutus Medical, AdAlta, AdaptivEndo, Advanced Accelerator Applications, Advanced Chemistry Development, Advanced Human Imaging, Advanced Nuclear Medicine Ingredients, Agena Bioscience, Agilent Technologies, Aidoc, Aiforia Technologies, AIG Hospitals, AI Medical Service, Akoya Biosciences, Albany Molecular Research, Albert Einstein College of Medicine, Alector, Alfasigma, Alibaba Health, Alimentiv, Allegheny Technologies, Alnylam Pharmaceuticals, Altris, Alume Biosciences, Alveo Technologies, Alzheimer's Drug Discovery Foundation, Amag Pharmaceuticals, Ambergen, Ambra Health, Ambry Genetics, American College of Cardiology, American College of Chest Physicians, American Health Imaging, AMRA, AMRA Medical, Amydis, Analytics 4 Life, AnchorDx, Andor Technology, Antaros Medical, Applied Spectral Imaging, APRINOIA Therapeutics, Arrayus Technologies, ARTBIO, Artialis, ARTMS Product, ARUP Laboratories, ASG Superconductors, Ashvattha Therapeutics, Asieris Pharmaceuticals, Aslan Pharma, Aspect Imaging, Aspen Imaging Healthcare, AssisTek, Astellas Pharma, AstraZeneca, Astrin Biosciences, Athinoula A Martinos Center for Biomedical Imaging, Athletic Heart Cardiac and Metabolic Testing, Austin Health, Avicenna Technology, Avinger, AVRA Surgical, Aytu BioPharma, BAMF Health, Banner Health, Baxter International, Bayer, Bay Labs, Baylor College of Medicine, BayPAT, BC Technical, Beckman Coulter, Belle.ai, Bethyl Laboratories, Biim Ultrasound, Bio-Techne, BioArctic AB, Biocare Medical, BioClinica, Biogen, BioMark Diagnostics, BiopharmX, Bioscience Pharma Partners, BioTek Instruments, BioTelemetry, Bioverativ, BioVolume, Blackford, BlackThorn Therapeutics, Blue Earth Diagnostics, Boehringer Ingelheim, BostonGene, Boston Medical Center, Boston Scientific, Bot Image, Bracco Imaging, Brain & Behavior Research Foundation, BrainLAB, Brainomix, BriaCell Therapeutics, Brigham and Women's Hospital, Broad Institute, Broncus Technologies, Bruker, Bruker Energy & Supercon Technologies (BEST), Butterfly Network, Calyx, Cambridge Research Biochemicals, Cancer Targeted Technology, Canon, Canon BioMedical, Cantel Medical, Caption Health, Cardiowise, Carestream Health, Carl Zeiss, Cartana, Case Western Reserve University, Catabasis Pharmaceuticals, CBD Solutions, Celgene, Cellares, CellSight Technologies, Censis Technologies, Centre for Addiction and Mental Health, Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre for Structural Systems Biology, CerebraCell, CereHealth, Cerevast Therapeutics, Cerveau Technologies, CgBio, Champalimaud Foundation, Champions Oncology, Check-Cap, CheckedUp, Children's Hospital Boston, China Grand Pharma, China Grand Pharmaceutical, Chinook Therapeutics, Circle cardiovascular imaging, Cirle, ClariPi, Claritas HealthTech, Clarius Mobile Health, Clarix, ClearLight Diagnostics, Clear Medical Imaging, ClearPoint Neuro, Cleveland Clinic, Client Outlook, Clinical Imaging Research Centre, Clinical Laserthermia Systems (CLS), Clovis Oncology, Cohen Veterans Bioscience, Colorado State University, Columbia University, Columbia University Medical Center, Compact Imaging, ConcertAI, Cone Health, Confo Therapeutics, Cornell University, Cortechs.ai, CorTechs Labs, Cosmo Pharmaceuticals, CrestOptics, Curasight, CureMetrix, Curium, CurveBeam AI, Cyclerion Therapeutics, CymaBay Therapeutics, CytoSite Bio, D&K Engineering, Dana-Farber Cancer Institute, Data Tecnica International, Deepcell, Deep Cube, DeepHealth, Defense Advanced Research Projects Agency, Definiens, Densitas, Dent Neurologic Institute, Department of Defense, Department of Veterans Affairs, DePuy, DiA Imaging Analysis, Diannei Biotechnology, Diaprost, Diaspective Vision, Dicom Systems, Disior, Diversigen, Dolbey, Draper Laboratories, DuChemBio, Duke University, Duke University Medical Center, DynamiCure Biotechnology, E.I. Medical Imaging, EchoNous, Eckert & Ziegler, Edan Instruments, Edinburgh Innovations, Edinburgh Molecular Imaging, Edwards Lifesciences, Eigen, Eisai, eKare, Eko, Elekta, Eli Lilly, Emergency Medicine Foundation, Emit Imaging, Emory University, Enable Medicine, Endoluxe, EndoSound, ENDRA Life Sciences, Enigma Biomedical, Envista, Epsilon, Erasmus University Medical Center, ERT, Essen University Hospital, Evotec, EXINI Diagnostics, Exo, Expesicor, Faes Farma, FASTVet, FEI, Ferronova, Ferrum Health, Fibrogen, FISBA, Flagship Biosciences, Florida Atlantic University Research, Fluidigm, Flywheel, Focal Healthcare, FogPharma, Fortis Therapeutics, Freenome, Fresenius, frog, Fujifilm, Fujifilm Irvine Scientific, Fujifilm medical systems, FUJIFILM SonoSite, Fulcrum Therapeutics, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, GBI BioManufacturing, GCS Sesan, GE Healthcare, Genentech, GeneQuantum Healthcare, GenesisCare, Geneva University Hospitals, Genomadix, Gentex, German Cancer Research Center, Gestalt Diagnostics, GI Reviewers, Global Health Labs, Global Lung Cancer Coalition, Google, Gradient Health, Growshapes, Guardant Health, Guerbet, Guided Therapeutics, Hadassah Medical Center, Hainan Sinotau Pharmaceutical, Halo Dx, HALO Precision Diagnostics, Halt Medical, Hamamatsu Photonics, Harvard Medical School, Harvard University, Healium Medical, HealthCare Konnect, Healthmark Industries, Healthy.io, Heartflow, HeartScore, Heidelberg Pharma, Hennepin County Medical Center, Henry Ford Health System, Henry M. Jackson Foundation, Heritage Valley Health System, Hermes Medical Solutions, HistoIndex, Hitachi, Hitachi Medical Systems Europe, Holobeam Technologies, Hologic, Hospital for Special Surgery, HOYA Corporation, HP, Huami, Huma, Huvitz, Hybridyne Imaging Technologies, Hyperfine Research, IBA, Ibex Medical Analytics, IBM Watson Health, iCAD, Icagen, Icometrix, ii Ventures, Ikonopedia, ImaBiotech, Image Analysis, ImageBiopsy Lab, ImageIQ, ImaginAb, Imaging Associates, Imaging Endpoints, Imago Systems, Imanova, Imbio, Imeka, ImmersiveTouch, iMotions, Imperial College London, Imperial Innovations, Imricor Medical Systems, IMRIS, Indiana University, Indica Labs, Indivumed, Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, Infervision, Infinitt, Inflazome, inHEART, InnerOptic Technology, Innodem Neurosciences, Innosuisse, Innovate BC, Inscopix, InSightec, Institut Curie, Intel, Intelligent Scopes, Intermountain Healthcare, International Association for the Study of Lung Cancer, IntroMedic, Invenio Imaging, inVentiv Health, inviCRO, Ionetix, IRIS International, iSchemaView, Isotopia Molecular Imaging, Item, Iterative Scopes, iThera Medical, ITM Isotopen Technologien, IXICO, Jain Foundation, Jana Care, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, JelloX Biotech, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Joslin Diabetes Center, Jubilant Radiopharma, Juntendo University, K2M, Kanazawa University, Kanteron Systems, Karl Storz, Keck School of Medicine of USC, Keio Gijuku University, Kent Imaging, Kettering Health, Kheiron Medical Technologies, Kings College London, Konica Minolta, Korea Pharma, Kubota Vision, Laboratory Corporation of America, Labrador Technologies, Lantheus Holding, Lantheus Medical Imaging, Lawson Health Research Institute, Leica Microsystems, LEO Pharma, Leucid Bio, LEXEO Therapeutics, Life Image, LifeOmic, LifeTech Scientific, Lightpoint Medical, Lipidomics Consulting, Lucence, Lumicell, LuminUltra, Lunaphore, Lung Cancer Initiative, Lunit, Luxel, M*Modal, MagCorp, Magellan Health Services, Magic Leap, Magle Chemoswed, Magnetic Insight, Mahidol University, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mauna Kea Technologies, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, McGill University, MD Anderson Cancer Center, MedAxiom, Medcase, Medexus Pharmaceuticals, MEDIAN Technologies, Medical Research Council, Medidata Solutions, Medis, Medis Medical Imaging, Mediso, Medovate, Medpace, medPhoton, MedQuest, Medtronic, MedyMatch, Meilleur Technologies, Melanoma Research Alliance, Memorial Hermann Health System, Memorial Sloan Kettering Cancer Center, Merck and Co, Merge Healthcare, Methodist Hospital Houston, Mevion Medical Systems, Michael J Fox Foundation, Michigan State University, Microsoft, MindPeak, Minerva Imaging, Mission Health, MITRO Biotech, MOBILion Systems, Molecular Instruments, MolecularMD, MolecuLight, Molnlycke Health Care, Montreal Neurological Institute-Hospital, Motus GI Medical Technologies, MRI Interventions, Munich Technical University, Myriad Genetics, Nano-X Imaging, NanoMab Technology, NASA, National Cancer Institute, National Cancer Institute of Mexico, National Center for Advancing Translational Sciences (NCATS), National Healthcare Services (NHS), National Institute of Biomedical Imaging and Bioengineering, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institutes of Health, National Institutes of Health Clinical Center, National Physical Laboratory, National Science Foundation, National University of Ireland, Galway (NUI Galway), Naval Medical Research Center, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigate Surgical Technologies, Navignostics, NDR Medical Technology, Nektar Therapeutics, Nelson Laboratories, Neosoma, NeraCare, NervGen Pharma, NE Scientific, Neuraly, Neuro42, Neuroelectrics, NeuroLogica, NeuroNexus, NeuroScience Associates, NeuroSense Therapeutics, NeuroVision Imaging, NeuSoft Medical Technologies, Neuvogen, New England Complex Systems Institute, New York University, NexOptic, NextGate, Nihon Medi-Physics, Nikon Corporation, Norgine, Noria Therapeutics, Northeastern University, NorthStar Medical Radioisotopes, Northwell Health, Northwestern Medicine Bluhm Cardiovascular Institute, NovAliX, Novarad, Novartis, Novo Nordisk, Novosound, NTT Data, Nuance Healthcare, Nucleo de Bioensaios Biossintese e Ecofisiologia de Produtos Naturais, Nuclidium, Numares, NuVasive, Nvidia, nView Medical, NX Development, NYtor, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, NZ Technologies, Ochre Bio, Olea Medical, Olympus, Olympus Respiratory America, OmniVision Technologies, Oncidium Foundation, One Lambda, OneMedNet, OnLume Surgical, ON Semiconductor, Onsite Women’s Health, OphtAI, Optellum, Optibrand, Optomed, Optos, OracleBio, Oregon Health Sciences University, OrthoGrid Systems, Osaka University, Oslo University Hospital, Othair Prothena, Otsuka, Otsuka America Pharmaceutical, oVio Technologies, Owkin, Owlstone Medical, Pacific Dental Services, Panacea Pharmaceuticals, Panaxium, Paracelsus Clinics, Parthenon Therapeutics, PathAI, PAVmed, Pennsylvania State University, Pepscan, PerkinElmer, Pfizer, PharmaCare Management, PharmaLogic, PhenoVista Biosciences, Philips, Philochem, Phoenix Children’s Hospital, Photocure ASA, Phytronix Technologies, Ping An Ventures, Piur Imaging, Planmeca, Planmed, Plus Therapeutics, POINT Biopharma, Polarean Imaging, Positron, PreciseDx, Precision for Medicine, Precision Image Analysis, Precision Optics, Premier Inc, PrinterPrezz, Profil Institute for Clinical Research, Progenics Pharmaceuticals, Promaxo, Proprio, Proscia, Provision Diagnostic Imaging, Purdue Research Foundation, Qlarity Imaging, QT Imaging, Qualigen, QuantalX Neuroscience, Quantinm, Quest Diagnostics, Quibim, Qure.ai, Rabin Medical Center (Beilinson Hospital), Radboud University Nijmegen Medical Centre, RadImageNet, Radiopharm Theranostics, RadNet, RapidAI, RareCyte, Ratio Therapeutics, RAW, ReadCoor, ReCor Medical, Redlen Technologies, RefleXion Medical, Remidio Innovative Solutions, Resolve Biosciences, RetinAI Medical, RetiSpec, Richardson Healthcare, Richard Wolf Medical Instruments, Riverain Medical, Roche, Rose F Kennedy Intellectual and Developmental Disabilities Research Center, ROTOP Pharmaka, Rouumtech, Royal Philips Electronics, Salk Institute, Salud Digna, Samsung Electronics, Sana Klinikum Offenbach, SandboxAQ, Sanford Health, Sanuwave Health, Satisfai Health, Sayre Therapeutics, SciBase, Science 37, Scil Proteins, SCIMAGE, Scintomics, Scivita Medical Technology, Scopio Labs, Screenpoint Medical, SecondWave Systems, Sectra, See-Mode Technologies, Segmed, SerenaGroup, Shanghai Pharmaceutical, Shared Medical Services, Shimadzu, Siemens Healthcare, Siemens Healthineers, SimBioSys, SimonMed Imaging, Singapore Bioimaging Consortium, Sinomed, Sirtex Medical, Smilow Cancer Hospital at Yale-New Haven (SCH), Sofie Biosciences, Solis Mammography, SomaServe, SonoScape Medical, SonoThera, Sony, SOPHiA Genetics, Soricimed Biopharma, Spectrum Dynamics, Spesana, SST Group, Standard BioTools, Stanford University, Stanford University School of Medicine, Statera Biopharma, StemoniX, Stereotaxis, Stockholm University, Storm ID, Strados Labs, Stratasys, Subtle Medical, Sumitomo Cryogenics, Sunnybrook Research Institute, Surfacide, Susan G. Komen for the Cure, Sutter Health, Swiss Institute of Allergy and Asthma Research, Swixx Biopharma, Synaptive Medical, Synopic, SyntheticMR, Sysmex, T3 Labs, Takeda Pharmaceutical, Tau Consortium, Techcyte, Teijin, Tel Aviv University, TeleMammography Specialists, Telemedicine Solutions, Telix Pharmaceuticals, TeraRecon, The Joint Pathology Center, Theragnostics, TheraPanacea, Therapixel, Thermo Fisher Scientific, The Technical University Of Munich, Thomas Jefferson University, Tissue Analytics, Tokyo Metropolitan Institute of Gerontology, toSense, Toshiba Medical Systems Corporation, Touchstone Medical Imaging, Transcriptome Sciences, Translational Research Institute for Space Health, TransMIT, Triage Technologies, TriSalus Life Sciences, TumorGen, Turner Imaging Systems, UK Biobank, Ultivue, UltraSight, United Imaging Healthcare, University College London, University Gastroenterology, University of Arizona, University of Augsburg, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Los Angeles, University of California San Francisco, University of Glasgow, University of Heidelberg, University of Hong Kong, University of Illinois, University of Konstanz, University of Lausanne, University of Leuven, University of Louisville, University of Manchester, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Michigan Medical School, University of Minnesota, University of New Mexico, University of North Carolina, University of Oxford, University of Pittsburgh, University of Queensland, University of Rennes, University of South Carolina, University of Virginia, University of Washington, University of Wisconsin-Madison, University of Wollongong, Uppsala University, UroPartners, UroViu, Us2.ai, US Air Force, USARAD, Usono, US Radiology Specialists, Vanderbilt University, Varian Medical Systems, Ventus Therapeutics, Verge Genomics, Verily, VIB, Vida Diagnostics, Vidence, Viewpoint Molecular Targeting, VIPUN Medical, Virginia Tech Intellectual Properties, Virgo Surgical Video Solutions, Visage Imaging, Visikol, VisionQuest Biomedical, Visiopharm, VisualDx, Vithas Group, Volk Optical, Volpara Solutions, VOTIS Subdermal Imaging Technologies, VU Medical Center, VUNO, WakeMed Health & Hospitals, Wallace H. Coulter Foundation, Waseda University, Washington University in St Louis, Waters Corporation, WaVe Lifesciences, Wayne State University, Weizmann Institute, WellDoc, Wellman Center For Photomedicine, Whiterabbit, Wilex, Windsong Radiology, Women & Infants Hospital of Rhode Island, XLIM, XPRIZE Pandemic Alliance, Yale School of Medicine, Yale University, Yantai Dongcheng Biochemicals, Yitu Medical, York Instruments, York University, Young Blood Institute, Zebra Medical Vision, Zepp Health, Zylox Tonbridge Medical Technology Co, Ltd

About Current Partnering

A definitive, evidence-based approach to dealmaking intelligence

Current Partnering is the industry-leading provider of pharmaceutical and biotech dealmaking intelligence, delivering a clear, structured, and evidence-based view of how partnerships are designed, negotiated, and executed in practice.

Our reports combine comprehensive deal coverage, structured data analysis, and contract-level insight, enabling a deeper understanding of how financial terms, rights, and responsibilities are defined across real-world transactions.

All reports are updated every six months, ensuring users have access to the latest deal activity, trends, and market developments.

---

Our methodology

Built on a continuously updated proprietary database

All analysis is underpinned by Current Agreements, our proprietary deals and alliances database which is updated daily by our analysts as new transactions are announced globally.

Deal records are continuously reviewed and enriched as additional information becomes available, ensuring accuracy, completeness, and relevance.

---

Comprehensive and verifiable data sourcing

Deal data is sourced from publicly available industry disclosures, including:

• Company press releases and announcements
• SEC filings and equivalent regulatory disclosures
• Company and investor presentations
• Conference materials and company websites

All sources are captured and referenced, enabling full transparency and user verification.

---

Broad coverage across deal types and structures

Current Partnering provides comprehensive coverage across a wide range of deal types, including but not limited to:

• Licensing and co-development
• Research and collaborative R&D
• Manufacturing, supply, and distribution
• Commercialisation and co-promotion
• Equity investments, joint ventures, and asset transactions
• Options, royalties, and financing agreements

This breadth ensures a complete view of how partnerships are structured across the life sciences sector.

---

Structured, standardised analysis

Every deal is analysed using a consistent framework, capturing (where disclosed):

• Financial terms — including upfront payments, milestones, and royalties
• Rights allocation — development, manufacturing, and commercialization responsibilities
• Deal structure — exclusivity, territorial scope, and agreement type
• Contractual provisions — clauses defining risk, control, and value-sharing

Each deal record is fully categorised, including data fields such as:

• Therapy area and technology type
• Stage of development
• Asset type and deal components
• Geographic scope and exclusivity
• Source documentation, including press releases and SEC filings

---

Financial normalisation for comparability

All financial values are standardised to USD using the exchange rate at the time of deal announcement, enabling consistent comparison of deal terms across geographies.

---

Contract-level insight

Where available, reports include direct access to underlying agreement documents, providing visibility into how deals are constructed in practice.

This enables users to understand:

• How financial mechanisms are defined and triggered
• How responsibilities are operationalised between parties
• How flexibility, risk, and control are allocated within agreements

---

Designed for real-world application

Current Partnering reports are built to support business-critical decision-making across the life sciences ecosystem, including:

• Pharmaceutical and biotech companies — benchmarking deals, structuring transactions, and supporting licensing strategy
• Investment firms and venture capital — assessing deal benchmarks, valuation expectations, and partner behaviour
• Advisory, legal, and consulting firms — supporting client engagements with real-world precedent and contract-level insight

Common use cases include:

• Benchmarking comparable transactions
• Supporting valuation and deal structuring
• Preparing for negotiations
• Evaluating potential partners
• Informing internal strategy with real-world evidence

---

A trusted industry reference

With a long track record in the sector, Current Partnering is relied upon by leading pharmaceutical companies, emerging biotechs, investors, and advisory firms as a trusted source of dealmaking intelligence.

By combining proprietary data, rigorous methodology, and contract-level insight, our reports provide a reliable and authoritative foundation for understanding how deals are structured, negotiated, and valued.